Updated:
PIVOTAL BIOVENTURE PARTNERS
PIVOTAL BIOVENTURE PARTNERS is an SEC-registered investment adviser in San Francisco, CA, established in 2017. It has been registered since then.
PIVOTAL BIOVENTURE PARTNERS
PIVOTAL BIOVENTURE PARTNERS is an SEC-registered investment adviser in San Francisco, CA, established in 2017. It has been registered since then. The firm is based in California.
General information
Firm type
Venture Capital
Sector focus
Frequently asked questions
Who runs investment decisions at Pivotal BioVenture Partners?
The firm does not publicly identify named principals or a CEO/CIO. Investment decisions are presumed to be made by a small team of life sciences professionals, consistent with typical family office governance.
How does Pivotal BioVenture Partners source proprietary deal flow?
The firm relies on relationships with academic institutions, biotech incubators, and co-investment networks, including collaborations with established biotech venture firms (per public records, 2023). It does not maintain a public deal-sourcing platform.
Is Pivotal BioVenture Partners structured as a single family office or does it operate more like a venture firm?
The firm operates as a family office with a venture capital bent, employing a direct-investment model without external LPs. This structure allows it to hold concentrated positions across multiple funding rounds without traditional fund constraints.
What investment stages does Pivotal BioVenture Partners typically target?
The firm targets seed through Series C stages, focusing on therapeutic companies with clear clinical pathways. It also participates in structured milestone-based financing rounds (per the firm's public communications, 2021).
Which sectors does Pivotal BioVenture Partners explicitly avoid?
The firm does not publicly disclose explicit avoidance of any sector, but its disclosed activity is exclusively in biotech and life sciences. It has not been observed investing in medical devices, diagnostics, or digital health.
Does Pivotal BioVenture Partners participate in fund commitments or only direct deals?
The firm is primarily a direct investor in companies, though it has co-invested alongside institutional fund managers. It does not appear to commit capital to external fund vehicles as a limited partner.
Where does the underlying wealth come from?
The source of the family wealth behind Pivotal BioVenture Partners has not been publicly disclosed. The firm's name suggests a connection to the biopharmaceutical industry, but no specific family or individual is named.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: